PDS Implant with Ranibizumab 100 mg/mL clinical trials

Extension Study for the Port Delivery System With Ranibizumab (Portal)

This study looks at a long-term eye implant to treat 'wet' age-related macular degeneration (nAMD). It checks the safety of the implant and how well it works over time in people who have been in previous studies. It also explores ways to manage potential side effects.